Turn annual reports into best-sellers

Turn annual reports into best-sellers
The Annual Report is too often underutilized in the literature racks of public companies. While thoroughly and sometimes even artfully detailing yearly achievement, it frequently fails to adequately compel investors, motivate employees, or inspire…

Read more on Portsmouth Herald

Clayton tech firm born at WU rarer than it should be

Clayton tech firm born at WU rarer than it should be
Seven years ago, Global Velocity’s data security technology was an interesting invention in Washington University’s Advanced Research Lab. Now it’s the basis of a company with 17 employees, $21 million in funding from investors and the beginnings of a commercial customer base.

Read more on St. Louis Post-Dispatch

T2 Biosystems takes in $15M Series C funding

T2 Biosystems takes in $15M Series C funding
Cambridge-based diagnostics developer T2 Biosystems Inc. reported today that it has received a $15 million funding from nine investors, and it plans to use the funds to accelerate the development and commercialization of its decentralized diagnostic platform.

Read more on Mass High Tech: The Journal of New England Technology

Taking Technical Risks: How Innovators, Managers, and Investors Manage Risk in High-Tech Innovations

Product Description
How do technology innovators, business executives, and venture capitalists manage the technical elements of business risk when developing and launching new products? Overcoming technical risks requires crossing the so-called valley of death–the gap between demonstrating the soundness of a technical concept in a controlled setting and readying the product technology for the market. Crossing the valley of death may mean bringing university-based research to the point where it appears viable to venture capitalists, or bridging the cultural gap between technical innovators and the managers who are being asked to risk their institutional resources. In every context, purely technical risks are coupled with the market risks inherent in innovation. In this book Lewis Branscomb and Philip Auerswald address early-stage, high-tech innovation in the context of business decision making and innovation policy. The topics addressed include the extent to which purely technical risk is separable from market risk; how industrial managers make decisions on funding early-stage, high-risk technology projects; and under what circumstances government can and should act to reduce the technical risks of innovative projects so that firms will invest in them. The book includes contributions by Mary Good, George Hartmann, James McGroddy, Mike Myers, Michael Roberts, and F. M. Scherer.

BUY FROM AMAZON–>> Taking Technical Risks: How Innovators, Managers, and Investors Manage Risk in High-Tech Innovations

Nanotech Fortunes: Make Yours in the Boom: Winning Strategies

Product Description
In small technologies, a rolling boom and bust cycle is set to begin. Why will most investors lose, while a few will make fortunes? Author Darrell Brookstein takes investors, scientists, entrepreneurs, executives, and venture capitalists on a wild, but insightful and practical, ride through the world of nanotech investing. Without the usual hype that typifies nanotech writing, Brookstein explains the never before revealed flies in the ointment that could relieve thousands of investors of their hard earned cash. Brookstein illuminates winning strategies for every market participant in this tiny niche that is poised to explode with dynamic investment opportunity.

BUY FROM AMAZON–>> Nanotech Fortunes: Make Yours in the Boom: Winning Strategies

Next Page »